EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT

BACKGROUND AND OBJECTIVE: Stroke is one of the leading causes of death and disability in the world. Previous studies have demonstrated that α-tocotrienol (α-TCT) and rosiglitazone (RGZ) reduce ischemic damage by middle cerebral artery (MCA) occlusion when administered before ischemic stroke in mice...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: MA Allahtavakoli, A Shamsizadeh, M Mahmoodi, R Moloudi, ME Rezvani
Formato: article
Lenguaje:EN
FA
Publicado: Babol University of Medical Sciences 2008
Materias:
R
Acceso en línea:https://doaj.org/article/49a63bd667664ece8c48bf56eb084b0e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:49a63bd667664ece8c48bf56eb084b0e
record_format dspace
spelling oai:doaj.org-article:49a63bd667664ece8c48bf56eb084b0e2021-11-10T09:07:36ZEFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT1561-41072251-7170https://doaj.org/article/49a63bd667664ece8c48bf56eb084b0e2008-08-01T00:00:00Zhttp://jbums.org/article-1-2465-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: Stroke is one of the leading causes of death and disability in the world. Previous studies have demonstrated that α-tocotrienol (α-TCT) and rosiglitazone (RGZ) reduce ischemic damage by middle cerebral artery (MCA) occlusion when administered before ischemic stroke in mice and rats. The aim of this study was to investigate the neuroprotective effects of α-TCT and RGZ at 3 hours after cerebral ischemia. METHODS: In this experimental study, stroke was induced by embolizing a preformed clot into the MCA. Male Wistar rats (300-350 gr) were assigned to α-TCT (1 or 10 mg/kg), rosiglitazone (RGZ) and sham-operation. The drugs were injected i.p. Stained brain sections were scanned and infarct area were determined using a picture analyzer software. FINDINGS: Forty eight hours after embolic ischemia, infarct volume in the control, RGZ, low and high doses of α-TCT were 29.4±2.6%, 15.9±3.1%, 24.9±2.1% and 29±4.8%, respectively. There was a significant difference between control and RGZ groups (p<0.05). Compared to the control group, the low and high doses of α-TCT didn’t show any significant difference. Furthermore, only RGZ decreased neurological deficits (p<0.05) and sensory impairments (p<0.01). CONCLUSION: Administration of α-TCT at 3 hr after induction of cerebral ischemia is not neuroprotective but RGZ may have beneficial effects on treatment and management of stroke. So further studies are needed to survey the neuroprotective effects of α-TCT after stroke.MA AllahtavakoliA ShamsizadehM Mahmoodi,R Moloudi,ME RezvaniBabol University of Medical Sciencesarticlecerebral ischemiaembolic modelα-tocotrienolvitamin eneuroprotectionMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 10, Iss 3, Pp 7-14 (2008)
institution DOAJ
collection DOAJ
language EN
FA
topic cerebral ischemia
embolic model
α-tocotrienol
vitamin e
neuroprotection
Medicine
R
Medicine (General)
R5-920
spellingShingle cerebral ischemia
embolic model
α-tocotrienol
vitamin e
neuroprotection
Medicine
R
Medicine (General)
R5-920
MA Allahtavakoli
A Shamsizadeh
M Mahmoodi,
R Moloudi,
ME Rezvani
EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
description BACKGROUND AND OBJECTIVE: Stroke is one of the leading causes of death and disability in the world. Previous studies have demonstrated that α-tocotrienol (α-TCT) and rosiglitazone (RGZ) reduce ischemic damage by middle cerebral artery (MCA) occlusion when administered before ischemic stroke in mice and rats. The aim of this study was to investigate the neuroprotective effects of α-TCT and RGZ at 3 hours after cerebral ischemia. METHODS: In this experimental study, stroke was induced by embolizing a preformed clot into the MCA. Male Wistar rats (300-350 gr) were assigned to α-TCT (1 or 10 mg/kg), rosiglitazone (RGZ) and sham-operation. The drugs were injected i.p. Stained brain sections were scanned and infarct area were determined using a picture analyzer software. FINDINGS: Forty eight hours after embolic ischemia, infarct volume in the control, RGZ, low and high doses of α-TCT were 29.4±2.6%, 15.9±3.1%, 24.9±2.1% and 29±4.8%, respectively. There was a significant difference between control and RGZ groups (p<0.05). Compared to the control group, the low and high doses of α-TCT didn’t show any significant difference. Furthermore, only RGZ decreased neurological deficits (p<0.05) and sensory impairments (p<0.01). CONCLUSION: Administration of α-TCT at 3 hr after induction of cerebral ischemia is not neuroprotective but RGZ may have beneficial effects on treatment and management of stroke. So further studies are needed to survey the neuroprotective effects of α-TCT after stroke.
format article
author MA Allahtavakoli
A Shamsizadeh
M Mahmoodi,
R Moloudi,
ME Rezvani
author_facet MA Allahtavakoli
A Shamsizadeh
M Mahmoodi,
R Moloudi,
ME Rezvani
author_sort MA Allahtavakoli
title EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
title_short EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
title_full EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
title_fullStr EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
title_full_unstemmed EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
title_sort effect of α-tocotrienol and proxisome prolifrative-activated receptor ligand on the brain ischemia in male rat
publisher Babol University of Medical Sciences
publishDate 2008
url https://doaj.org/article/49a63bd667664ece8c48bf56eb084b0e
work_keys_str_mv AT maallahtavakoli effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat
AT ashamsizadeh effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat
AT mmahmoodi effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat
AT rmoloudi effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat
AT merezvani effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat
_version_ 1718440277787541504